INFORMAZIONI SU QUESTO EPISODIO
When designing a trial for cutaneous lupus erythematosus (CLE), consider earlier primary endpoints, limited background therapy, and balanced racial representation to address placebo response. That’s just a few of the insights from the first-ever systematic review of placebo response in CLE trials, shared here by Dr. Stéphanie Légaré, first author of Placebo Response in Randomised Controlled Trials of Systemic Therapies for Cutaneous Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Want more on placebo response in rheumatology trials? Learn from leading KOLs Drs. Andreas Kerschbaumer and Joan Merrill at a free educational breakfast event happening during ACR Convergence 2026. Register here: https://go.inderocro.com/podcast/description/episode-43/acr-bf-registration.
Want more on placebo response in rheumatology trials? Learn from leading KOLs Drs. Andreas Kerschbaumer and Joan Merrill at a free educational breakfast event happening during ACR Convergence 2026. Register here: https://go.inderocro.com/podcast/description/episode-43/acr-bf-registration.
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di Phase Forward.
ALTRI EPISODI IN QUESTO PODCAST
In this episode of Phase Forward, Dr. Ana Palijan explores how early phase clinical trials have evolved beyond their traditional safety focus. With over 25 years in translational research, she discusses the growing complexity driven by scientific advances, technology integration, and global trial e…
In the Season 3 finale of Phase Forward, clinical research veterans Ted Trafford and Brad Hightower share essential insights on building stronger collaborations between sponsors, CROs, and clinical trial sites. Drawing from decades of hands-on experience, they explore how sustained site motivation,…
In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promo…
In this episode, Isabel Dorion, Senior Director of Clinical Operations at Indero, shares expert insights on the critical role of Clinical Research Associates (CRAs) in ensuring trial quality and patient safety. Explore key strategies for effective CRA oversight and discover how quality reviews and …
In this episode, Sarah Ballard, Agency Director at KDM, dives into the strategic power of PR in navigating the complex world of scientific and clinical communications. With over 20 years in B2B marketing, Sarah reveals how public relations drives trust and credibility amid digital disruption and st…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Phase Forward, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
